FDA approves Pfizer vaccine for kids
Children age 12 to 15 could begin receiving COVID-19 vaccinations as soon as Thursday after federal regulators approved the use of the vaccine in that age group on Monday.
The emergency use authorization of the Pfizer/BioNTech vaccine comes after months of trials that showed the vaccine was 100% effective at preventing coronavirus infection in children.
The move could provide a huge boost to vaccination efforts in the U.S., which have been waning in recent weeks. It could also be a boon to schools ahead of the fall.
Studies showed the vaccine had the same side effects in children as in adults: Muscle soreness around the injection site, flu-like symptoms, and fatigue.
You can read more on APNews.
The average story costs NowKalamazoo $400 to produce. Donate to fund stories like this.
Thank you to the community institutions that support our work:
